5047-77-8

Basic information

• Product Name: 4-hydroxy-3,5-dimethoxyphenylmethylamine hydrochloride
• Synonyms: 4-hydroxy-3,5-dimethoxyphenylmethylamine hydrochloride
• CAS NO: 5047-77-8
• Molecular Weight: 219.668
• Mol File: 5047-77-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-hydroxy-3,5-dimethoxyphenylmethylamine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-hydroxy-3,5-dimethoxyphenylmethylamine hydrochloride(5047-77-8)
• EPA Substance Registry System: 4-hydroxy-3,5-dimethoxyphenylmethylamine hydrochloride(5047-77-8)

Safety Data

• Hazardous Substances Data: 5047-77-8(Hazardous Substances Data)

Upstream product

• 5032-13-3 4-hydroxy-3,5-dimethoxybenzaldehyde oxime 
• 134-96-3 syringic aldehyde 

Relevant articles and documents

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT

N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF

The present invention provides N6-substituted adenosine derivatives and N6-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.